| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |